# Clustering Approach 3 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0807170412261626	Range of duration = 0.89 to 133.25, nDeath = 10, nCensor = 107
2	AGE	ANOVA	0.517963717476424	Range of values = 35 to 90, Mean = 63.1026, StdDev = 10.9122
3	HISTOLOGICAL.TYPE	Chi-square test	1.69071327897295e-10	nTypes = 6 (ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3)/MIXED SEROUS AND ENDOMETRIOID/UTERINE SEROUS ENDOMETRIAL ADENOCARCINOMA), nPatients = 62/3/2/32/1/17
4	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.611239192547567	nTypes = 2 (NO/YES), nPatients = 54/63
5	NEOADJUVANT.THERAPY	Fisher's exact test	0.0116235459249245	nTypes = 2 (NO/YES), nPatients = 81/36